Showing results (501-510 of 526) with videos related to

Sort By:
Pageof 53
Korean Circulation Journal|August 5, 2015
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive PatientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
European Heart Journal|November 19, 2025
Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trialSeung-Jun Lee, Seung-Jae Lee, Sung-Jin Hong, et al.
Lancet (London, England)|September 5, 2024
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South KoreaSung-Jin Hong, Seung-Jun Lee, Sang-Hyup Lee, et al.
Clinical Therapeutics|December 18, 2017
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI StudyKi-Chul Sung, Yong-Seog Oh, Dong-Hun Cha, et al.
JAMA|June 26, 2019
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical TrialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
The International Journal of Cardiovascular Imaging|May 29, 2026
Optical coherence tomography-guided PCI in left anterior descending versus non-left anterior descending lesions: a prespecified substudy of the OCCUPI trialSoo-Jin Kim, Seung-Jun Lee, Sung-Jin Hong, et al.
JAMA Cardiology|September 28, 2022
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical TrialKi Hong Choi, Yong Hwan Park, Young Bin Song, et al.
American Heart Journal|February 8, 2023
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trialSoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Journal of the American Heart Association|December 21, 2020
Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE TrialKyeong Ho Yun, Seung-Yul Lee, Byung Ryul Cho, et al.
Heart (British Cardiac Society)|March 24, 2021
P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitorJuwon Kim, Woo Jin Jang, Wang Soo Lee, et al.
Pageof 53